Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filedfiledCritical
Priority to ECSP003541priorityCriticalpatent/ECSP003541A/es
Publication of ECSP003541ApublicationCriticalpatent/ECSP003541A/es
208000037265diseases, disorders, signs and symptomsDiseases0.000abstract1
229940079593drugDrugs0.000abstract1
Landscapes
Medicines That Contain Protein Lipid Enzymes And Other Medicines
(AREA)
Abstract
La invención se refiere al uso de una combinación de al menos un inhibidor de MTP seleccionado (componente A) y un inhibidor de HMg-CoA reductasa (componente B) para la lucha contra enfermedades del sistema cardiocirculatorio, a medicamentos que contienen esta combinación y a su obtención.
ECSP0035412000-06-232000-06-23COMBINACION DE INHIBIDORES DE MTP E INHIBIDORES DE HMG CoA REDUCTASA Y SU USO EN MEDICAMENTOS
ECSP003541A
(es)
formas de dosagem fornecendo liberação controlada de inibidores de proteìna de transferência de ésteres de colesterila e liberação imediata de inibidores de hmg-coa redutase